Denali Therapeutics Down After Proposing To Sell $250 Million Of Shares

On:

Shares of Denali Therapeutics Inc. (DNLI) are falling more than 9% Wednesday morning at $29.60.

The company today said it proposes offer for sale of $250 million of shares.

DNLI has traded in the range of $20.24-$56.08
in the last 52 weeks.

Source: Read Full Article

Lates News:
  1. Pundit's $100,000 Bitcoin Price Target By Next Halving Sparks Exciting Bet
  2. Crypto Analyst: ‘This Is Historically the Optimal Time To Allocate to Bitcoin’
  3. Standard Chartered Sees Bitcoin Breaking 2024 With A Mind-Blowing BTC Moonshot To $100,000 Price
  4. $ETH: CME Group Shows Impeccable Timing With Launch of Its Options on Ether Futures
  5. Travelers Companies Rises On Better-than-expected Earnings, Share Buyback